+91-8668442535

Dental Bone Graft Substitutes And Other Biomaterials Market By Raw Material (Natural, Ceramic, Composite, Polymer) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Industry Outlook

The dental bone graft substitute and other biomaterials market is set to reach US$ 1,786.0 million by 2026 from US$ 740.3 million in 2017, highlighting impressive growth at a compounded annual growth rate (CAGR) of 10.3% during the forecast period from 2018 to 2026. As per the statistics provided by the Global Burden of Disease Study (GBD), periodontitis is considered the sixth most prevalent disease worldwide, affecting approximately 743 million people worldwide. The global prevalence rate of periodontitis is 11.2%. Factors responsible for the disease's etiology are chewing tobacco and betel nuts, craving sugary foods, and poor oral hygiene.

Bone grafts are commonly used in dental implants to restore the edentulous area around missing teeth. They are frequently used to repair fractured jawbones and promote dental bone healing. Since 2015, the US Food and Drug Administration has prohibited the use of dental bone grafts and other biomaterials in patients under the age of 18. Changing regulatory norms are a setback to the dental bone graft substitute market.

Market Synopsis

Excellent osteoconduction and osteoinduction properties make allograft the most desired dental bone graft.

Allograft is usually taken from cadavers that have donated their bones, and it is sourced from a bone bank. Due to their excellent osteoconduction and osteoinduction properties, they are frequently used in reconstructive dental procedures as structural and particulate grafts. The sterilization of allografts is a very critical procedure, as incidences of disease transmission or reaction have been reported. Xenografts are obtained from non-human species, such as bovine and coral sources, which find prominence in dental surgeries as the calcified matrix. Ceramic material will be a trendsetter throughout the forecast period on account of its enhanced osseointegration properties. It can be used alone or in combination with calcium phosphate and bioactive glass to give a structural base for dental implants to the jawbones that have deformed due to severe atrophy.

The increasing number of dental surgeries performed will propel the market for dental bone graft substitutes and other biomaterials in North America.

North America is currently leading the regional segment. The key factors responsible for the dominance of North America are the increasing number of dental surgeries performed and the rising geriatric population with jawbone deformities. Healthcare insurers have started providing favorable reimbursements to their customers who opt for dental bone graft surgical procedures. The presence of major players such as DENTSPLY International, Inc., Institut Straumann AG, Geistlich Pharma AG, and others in Europe drives the dental bone graft market.

The European Medical Agency's (EMA) supportive regulatory scenario in expediting product approval results in positive traction for the dental bone graft market. Asia Pacific serves as an attractive destination for the business expansion of dental bone graft substitutes and other biomaterials by establishing subsidiaries and retail outlets for key players. An increasing number of patients are suffering from oral health issues such as eroded crowns and jawbone atrophy due to chewing tobacco and betel nuts. Rampant growth in medical tourism due to affordable dental surgical procedures has had a positive impact on the dental bone graft substitutes and other biomaterials market in Asia Pacific.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The latest market trends were studied to determine the compounded annual growth rate and market estimation. The market is divided into two sections: material and region.

A thorough market assessment was conducted to understand the organic and inorganic market growth strategies applied by key players manufacturing bone graft substitutes and other biomaterials. Existing competition among key players is mapped under the competitive landscape segment. A diverse range of dental bone graft substitutes is covered in the product portfolio segment. Archrivals competing in the market are ACE Surgical Supply Company, Inc., Geistlich Pharma AG, Biohorizons IPH, Inc., Sigma Graft Biomaterials, Biomet, Inc., DENTSPLY International, Inc., DePuy Synthes Companies, Institut Straumann AG, Medtronic, Plc., and Zimmer Holdings, Inc.

Key questions are answered in this report.

  • How is the market assessment performed, employing organic and inorganic market growth strategies?
  • Who are the key players dominating the dental graft market?
  • What are the drivers, challenges, and opportunities pertaining to the dental graft market?
  • How is the competitive landscape mapped to understand the existing competition among major players?
  • Which is the leading and fastest-growing material segment for the dental bone graft substitutes and other biomaterials market?
  • Which is the leading and fastest-growing regional segment for the dental bone graft substitutes and other biomaterials market?

Frequently Asked Questions:

The market for Dental Bone Graft Substitutes And Other Biomaterials Market is expected to reach US$ 1,786.0 Mn by 2026.

The Dental Bone Graft Substitutes And Other Biomaterials Market is expected to see significant CAGR growth over the coming years, at 10.3%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Geistlich Pharma AG, Biohorizons IPH, Inc., Sigma Graft Biomaterials, Biomet, Inc., DENTSPLY International, Inc., DePuy Synthes Companies, Institut Straumann AG, Medtronic, Plc are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Nov 2018
Category:  Medical Devices
Report ID:   59427
Report Format:   PDF
Pages:   120
Rating:    4.4 (69)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support